Karyopharm Therapeutics Inc.
KPTI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$76 | -$143 | -$165 | -$124 |
| Dep. & Amort. | $0 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $1 |
| Stock-Based Comp. | $18 | $22 | $35 | $30 |
| Change in WC | -$0 | $31 | -$20 | -$23 |
| Other Non-Cash | -$70 | -$3 | -$0 | $8 |
| Operating Cash Flow | -$127 | -$93 | -$150 | -$107 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | $0 | -$0 | -$6 |
| Net Acquisitions | $0 | $0 | $104 | $6 |
| Inv. Purchases | -$59 | -$159 | -$226 | -$45 |
| Inv. Sales/Matur. | $154 | $167 | $122 | $193 |
| Other Inv. Act. | $0 | $0 | -$104 | -$6 |
| Investing Cash Flow | $95 | $8 | -$104 | $142 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $83 | $0 | $0 | $60 |
| Stock Issued | $1 | $1 | $190 | $10 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$43 | $0 | $4 | $4 |
| Financing Cash Flow | $42 | $1 | $194 | $74 |
| Forex Effect | -$0 | -$0 | -$0 | -$0 |
| Net Chg. in Cash | $10 | -$84 | -$61 | $108 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $53 | $137 | $197 | $89 |
| End Cash | $63 | $53 | $137 | $197 |
| Free Cash Flow | -$128 | -$93 | -$150 | -$113 |